Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.02 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: misoprostol, dinoprostone, sepetaprost | 1.00 |
| trials ClinicalTrials.gov | 2 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 2 Parkinson's papers of 167 | 0.85 |
| pathways Reactome | 2 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 7195
Sealed predictions
- PTGER3 in dopamine neurons, braak+0.63 (p 0.068) → +0.12 (p 0.760)receipt 7201
Swarm cases
receipt 7201: PTGER3 in dopamine neurons, braak
- power
- full sample +0.42 (p 0.084, n 18), 95% CI -0.06 to +0.74. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.39 (p 0.107, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.44 (p 0.070, n 18). could be the mix.
- skeptic
- leave-one-out range +0.34 to +0.60, sign flips 0; without severely affected donors +0.42 (p 0.084, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PTGER3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts